May 22, 2014, 16:00 PM by Michael Croft

San Francisco Business Times | An ex-Ion Torrent scientist has a $35 million investment to prove his new sequencer is faster and cheaper than anything else.

May 22, 2014, 07:55 AM by Michael Croft

Bio-IT World | Presenters at the annual meeting of the American Society for Microbiology showed off new applications for the CRISPR system of gene editing, and projects that have re-coded bacterial genomes on a massive scale.

May 22, 2014, 07:00 AM by Michael Croft

Bio-IT World News Brief | GenePeeks has opened its in silico nursery, formally launching the Matchright screening service for families who are planning to use a sperm donor to conceive.

May 21, 2014, 13:00 PM by Michael Croft

Bio-IT World News Brief | Mayo Clinic and N-of-One, have signed an agreement under which N-of-One will provide Mayo Clinic with clinical interpretation information to aid in highly complex molecular diagnostics.

May 21, 2014, 12:00 PM by Michael Croft

Bio-IT World News Brief | QIAGEN is adding content from BIOBASE including HGMD, the human gene mutation database, to its bioinformatics offerings. HGMD and other BIOBASE solutions will provide the foundation for Ingenuity Clinical, QIAGEN's forthcoming clinical NGS decision-support solution.

May 21, 2014, 07:00 AM by Michael Croft

Bio-IT World | At the Prenatal Molecular Diagnostics Europe conference last week in Lisbon conversations ranged from the current landscape in prenatal diagnostics to the future vision of the technology and the regulatory environment that will enable it.

May 20, 2014, 12:00 PM by Michael Croft

May 20, 2014, 00:00 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - May 20, 2014 -  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced it has added 14 professionals to its Research Triangle Park team in April and has plans to hire an additional 25 more team members as part of its growth expansion strategy in 2014

May 19, 2014, 12:30 PM by Michael Croft

Bio-IT World | On Friday, a frank assessment of AstraZeneca's R&D practices appeared in Nature Reviews Drug Discovery, just as Pfizer's repeated takeover bids have increased scrutiny of AstraZeneca's drug development pipeline.

May 19, 2014, 08:00 AM by Michael Croft

Bio-IT World | With a close partnership with Eric Schadt’s Icahn Institute for Genomics at Mt. Sinai, LifeMap Solutions is an intriguing – though closely-guarded – entrant into the renewed rush to provide genetic health information to patients.

May 19, 2014, 00:00 AM by Michael Croft

BOULDER, PA, UNITED STATES - May 19, 2014 - Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointments of Nicholas A

May 15, 2014, 12:05 PM by Michael Croft

Bio-IT World News Brief | BaseHealth, whose platform Genophen uses patients' unique genetic and clinical profiles to assess their personal health risks, today announced a tightening of its relationship with Illumina.

May 15, 2014, 08:50 AM by Michael Croft

Bio-IT World | At this April's Bio-IT World Conference & Expo, representatives from the Broad Institute and Novartis presented new tools for bioassays and drug development.

May 15, 2014, 08:10 AM by Michael Croft

Nature | The NIH yesterday announced new policies to correct a tendency to study male cells and animals in preclinical research, including a requirement that applicants for NIH grants disclose the balance of male and female models used in their studies.

May 14, 2014, 13:10 PM by Michael Croft

Bio-IT World | Ayasdi, an informatics company whose topological analysis platform searches for unpredictable patterns in large datasets, is expanding its footprint in the life sciences with new products and partnerships.

May 14, 2014, 00:00 AM by Michael Croft

BOULDER, CO, UNITED STATES - May 14, 2014 - Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 – June 3, 2014 in Chicago, Illinois

May 13, 2014, 08:55 AM by Michael Croft

Boston Globe | The Broad Institute of MIT and Harvard has announced layoffs of 27 employees involved in contract work for the NIH-funded Molecular Library Probe Center Network.

May 13, 2014, 00:00 AM by Michael Croft

BOULDER, CO, UNITED STATES - May 13, 2014 - Array BioPharma Inc. (NASDAQ: ARRY) continues recruitment for its ongoing Phase 3 clinical study in patients with low-grade serous ovarian cancer (LGSOC)

May 12, 2014, 09:50 AM by Michael Croft

Bio-IT World | Helen Berman, a professor of chemistry and chemical biology at the Center for Integrative Proteomics Research at Rutgers University, was honored with the Benjamin Franklin Award at the 2014 Bio-IT World Conference & Expo for her work building the Protein Data Bank.

May 12, 2014, 09:40 AM by Michael Croft

Bio-IT World News Brief | After weeks of rejected offers to acquire AstraZeneca, and public skepticism over the outcome of such a deal, Pfizer this morning released a series of videos promoting the potential merger as a boon to science.